Brief: Cullinan Therapeutics- Cullinan Amber Notified MIT Decision To Terminate Exclusive Patent License Agreement For Cln-617

Cullinan Therapeutics

21/11/2025 22:07

Nov 21 (Reuters) - Cullinan Therapeutics Inc CGEM.O:

CULLINAN THERAPEUTICS- CULLINAN AMBER NOTIFIED MIT DECISION TO TERMINATE EXCLUSIVE PATENT LICENSE AGREEMENT FOR CLN-617

Further company coverage: CGEM.O

 ((Reuters.Briefs@thomsonreuters.com;))